Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Canine Graft-versus-Host Disease

Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation

Abstract

Several steroid receptor-associated heat shock proteins can bind to FK506 as immunophilins. This has led to speculation that the steroid receptor and immunophilin signal transduction pathways are functionally interrelated. Indeed, in vitro work showed that FK506 treatment of intact L929 cells which were stably transfected with various reporter plasmids resulted in a potentiation of glucocorticoid hormone-induced glucocorticoid receptor-mediated gene transcription. These findings have raised the possibility of additive or synergistic immunosuppressive effects of FK506 and glucocorticoids. We tested this hypothesis in a canine model of GVHD prevention. Two groups of dogs were given 9.2 Gy total body irradiation followed by hematopoietic grafts from unrelated DLA-nonidentical donors. Among the first group of four recipients which were given FK506 and glucocorticoids, one rejected the graft, while three developed acute GVHD and died from associated complications between days 14 and 34. In the second group of nine recipients which were given FK506, glucocorticoids and methotrexate (MTX), only one dog became a long-term survivor while eight dogs died between days 21–114 with GVHD (n = 5) or FK506-associated toxicities (n = 3). Thus, addition of glucocorticoids to FK506 or FK506/MTX showed neither synergistic nor additive effects with respect to GVHD prevention in this model, and no survival advantages were seen compared to previously reported results with FK506 alone or FK506 and MTX in combination, respectively.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, C., Seidel, K., Fitzsimmons, W. et al. Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation. Bone Marrow Transplant 20, 137–141 (1997). https://doi.org/10.1038/sj.bmt.1700863

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1700863

Keywords

Search

Quick links